An Emotion-Focused Intervention for Glycemic Control in T2D
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03553680|
Recruitment Status : Recruiting
First Posted : June 12, 2018
Last Update Posted : June 12, 2018
|Condition or disease||Intervention/treatment||Phase|
|Type2 Diabetes||Behavioral: Emotion-Focused CBT||Not Applicable|
Our interest in aberrant Emotional Regulation / Emotional Intelligence in Type 2 Diabetes stems from observations that while many patients with Type 2 Diabetes have greater incidence of mood and anxiety (and even anger) disorders than controls, targeting psychiatric conditions, such as depression, is not sufficient to improve glycemic control in patients with diabetes. Thus, the key issue for such patients is not what specific psychiatric disorder they have, but the presence of an impairment in the fundamental regulation of emotional regulation and in how such individuals modulate their emotional response to aversive events in their lives (e.g., emotional intelligence), now suggested by a recent study. As part of a new study,4 we examined the relationship between glycemic control (HbA1c) and Emotional Regulation and Emotional Intelligence in 100 adult patients with Type 2 Diabetes. We found significant relationships between Emotional Regulation and Emotional Intelligence and HbA1c levels that accounted for nearly 24% of the variance in HbA1c levels. These relationships with HbA1c levels remained even after accounting for other relevant behavioral variables such as depression/anxiety scores and diabetes self-care/literacy scores. Accordingly, the tendency of an individual to have intense emotional responses (Emotional Regulation), and/or to have a reduced ability to understand/modulate one's emotions in order to cope with daily stresses/threats (Emotional Intelligence), may well be linked with poor glycemic control (HbA1c) in adult patients with Type 2 Diabetes. If so, it will be important to develop psychosocial methods to improve Emotional Regulation and Emotional Intelligence in Type 2 Diabetes patients to determine if one can improve aberrant Emotional Regulation / Emotional Intelligence and HbA1c levels as suggested by treatment studies showing that such treatment can improve Emotional Intelligence scores with a sustained reduction in HbA1c levels in Type 2 Diabetes for up to nine months. Supporting these findings are data from a recent study showing that increasing positive emotion reduces blood glucose levels, especially in those with poor emotion regulation skills.
Specific Study Objectives:
- Develop an integrated Emotion Regulation / Emotional Intelligence-Focused Psychosocial Intervention from three (3) existing sources that contain Emotional Regulation and Emotional Intelligence Psychosocial Intervention elements for the treatment of behavioral conditions.
- Conduct a pilot study in 10 patients with Type 2 Diabetes with aberrant Emotional Regulation and Emotional Intelligence and compare treatment outcomes in Emotional Regulation, Emotional Intelligence, and in HbA1c with 10 patients with Type 2 Diabetes undergoing treatment as usual.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||Emotion-Focused CBT|
|Official Title:||An Emotion-Focused Psychosocial Intervention for Improved Glycemic Control in T2D Patients: A Pilot Study|
|Actual Study Start Date :||October 20, 2017|
|Estimated Primary Completion Date :||October 19, 2018|
|Estimated Study Completion Date :||October 19, 2018|
Experimental: Emotion-Focused CBT
Ten CBT sessions with a therapist.
Behavioral: Emotion-Focused CBT
10 CBT Sessions to improve emotional regulation and emotional intelligence.
No Intervention: Wait List
Three visits for assessments only over the same time period of the Experimental Arm.
- Change in the Score on "Negative Emotional Reactivity" on the Affect Intensity Measure (AIM) Scale. [ Time Frame: Baseline and end-point (about 10-12 weeks). ]Intensity of negative emotional reactivity. Range from 6 to 36, higher scores indicate greater intensity of negative emotional reactivity.
- Change Score on the "Clarity of Emotion" on the Trait Meta Mood (TMM) scale for emotional intelligence. [ Time Frame: Baseline and end-point (about 10-12 weeks) ]Assessment of clarity of emotions. Range from 0 to 44; higher scores indicate greater emotional intelligence.
- HbA1c level [ Time Frame: Baseline and end-point (about 10-12 weeks) ]HbA1c levels
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03553680
|Contact: Emil F Coccaro, MDfirstname.lastname@example.org|
|United States, Illinois|
|University of Chicago||Recruiting|
|Chicago, Illinois, United States, 60637|
|Contact: Emil F Coccaro, MD|
|Principal Investigator:||Emil F Coccaro, MD||University of Chicago|